<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Jef Vanhamel</style></author><author><style face="normal" font="default" size="100%">Eline Wijstma</style></author><author><style face="normal" font="default" size="100%">Jessika Deblonde</style></author><author><style face="normal" font="default" size="100%">Laga, Marie</style></author><author><style face="normal" font="default" size="100%">Vuylsteke, Bea</style></author><author><style face="normal" font="default" size="100%">Nöstlinger, Christiana</style></author><author><style face="normal" font="default" size="100%">Noori, Teymur</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Developing evidence-informed indicators to monitor HIV pre-exposure prophylaxis programmes across EU/EEA countries: a multi-stakeholder consensus</style></title><secondary-title><style face="normal" font="default" size="100%">Eurosurveillance</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Europe</style></keyword><keyword><style  face="normal" font="default" size="100%">HIV</style></keyword><keyword><style  face="normal" font="default" size="100%">Monitoring</style></keyword><keyword><style  face="normal" font="default" size="100%">PrEP</style></keyword><keyword><style  face="normal" font="default" size="100%">prevention</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2023</style></year><pub-dates><date><style  face="normal" font="default" size="100%">Aug-06-2023</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">28</style></volume><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p&gt;Several countries in the European Union (EU) and European Economic Area (EEA) established and/or scaled up HIV pre-exposure prophylaxis (PrEP) programmes between 2016 and 2023. Data on PrEP programmes’performance and effectiveness in reaching those most in need will be needed to&amp;nbsp;assess regional progress in the roll-out of PrEP.&amp;nbsp;&lt;br&gt;
However, there is a lack of commonly defined&amp;nbsp;indicators for routine monitoring to allow for&amp;nbsp;minimum comparability. We propose a harmonised PrEP monitoring approach for the&amp;nbsp;&lt;br&gt;
EU/EEA, based on a systematic and evidence-informed consensus-building process involving a broad and multidisciplinary expert panel. We present a set of indicators, structured along relevant steps of an adapted PrEP care continuum, and offer a&amp;nbsp;prioritisation based on the degree of consensus among the expert panel. We distinguish&lt;br&gt;
between ‘core’ indicators deemed essential for any PrEP programme in the EU/EEA,&amp;nbsp;vs ‘supplementary’ and ‘optional’ indicators that provide meaningful data, yet where experts evaluated their feasibility for data collection and reporting as very context-dependent. By combining a&amp;nbsp;standardised approach with strategic opportunities for adaptation and complementary research, this monitoring framework will contribute to assess the impact of PrEP on the HIV epidemic in Europe.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">23</style></issue></record></records></xml>